USE AND ABUSE OF MUSCLE RELAXANTS
3:45 pm - 5:00 pm, O’Neill Room - 4th Floor
Course Code: F-04
Speaker: AARON F. KOPMAN, M.D.
Dr. Kopman - Receives consultant fees, honoraria and is on the speakers bureau for Schering-Plough.
Objective(s):
Objective(s):
° Discuss the clinical issues surrounding undetected post-operative neuromuscular blockade;
° Employ techniques using neuromuscular blocking agents for short procedures;
° Discuss new strategies for reversal of neuromuscular blockade;
° Integrate into their practice methods to avoid undetected post-operative residual neuromuscular blockade;
° List the indications for neuromuscular blocking agents use in the ICU;
° Identify the sequelae associated with the use of neuromuscular blocking agents in the ICU;
° Develop a plan for management of critically ill patients requiring neuromuscular blockade in the ICU.
Neuromuscular Blockade For Short Procedures and New Developments in Reversal Strategies
Neuromuscular Blocking Agents in Critical Care
|
